Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (46,600)	$ (94,100)
Adjustments to reconcile net loss to net cash used in operating activities:
Impairment of acquired contract intangible asset	3,724	74,156
Share-based compensation expense	6,773	723
Amortization of premiums and discounts on short-term investments, net	(149)	0
Change in fair value of convertible promissory notes	0	(1,585)
Non-cash interest expense	0	584
Gain upon extinguishment of debt	0	(196)
Non-cash lease expense	270	133
Depreciation and amortization expense	113	33
Changes in operating assets and liabilities:
Accounts receivable	(2,261)	14,149
Inventory	(734)	0
Prepaid expenses and other current assets	(1,578)	(526)
Other non-current assets	365	430
Operating lease liability	(170)	(121)
Accounts payable and accrued liabilities	1,917	4,860
Other liabilities	0	(8,535)
Net cash used in operating activities	(38,330)	(9,995)
Cash flows from investing activities:
Purchases of property and equipment	(366)	0
Purchase of short-term investments	(48,141)	0
Cash acquired in connection with the Merger	0	29,700
Transaction expenses related to the Merger	0	(4,501)
Net cash (used in) provided by investing activities	(48,507)	25,199
Cash flows from financing activities:
Proceeds from sale of common stock and prefunded warrants	72,500	0
Issuance of common stock upon exercise of stock options	396	745
Issuance of common stock to PIPE Investors	0	155,000
Costs incurred in connection with issuance of common stock	0	(9,617)
Dividends paid	0	(4,412)
Issuance of common stock upon exercise of warrants	54	0
Deferred offering costs paid for financing	(223)	0
Net cash provided by financing activities	72,727	141,716
Net (decrease) increase in cash, cash equivalents and restricted cash	(14,110)	156,920
Cash, cash equivalents and restricted cash at beginning of year	148,989	4,455
Cash, cash equivalents and restricted cash, end of period	134,879	161,375
Supplemental disclosure of cash flow information:
Interest paid during the period	173	0
Taxes paid during the period	9	0
Issuance of common stock upon Merger	0	105,888
Conversion of promissory note into common stock upon Merger	0	9,130
Supplemental disclosure of non-cash activities:
Costs incurred in connection with Private Placement included in accounts payable	322	0
Deferred transaction costs included in accounts payable and accrued liabilities	75	0
Accrued property and equipment	60	0
Operating lease liability arising from obtaining right-of-use asset	$ 1,210	$ 610